Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-marketing study of Pegasys in chronic hepatitis C (non-genotype 1b high viral load)
jRCT1080220157Phase 4
- Sponsor
- Chugai Pharmaceutical Co., Ltd.
- Start
- Oct 2005
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of interferon alfa in hepatitis C virus infection, sponsored by Chugai Pharmaceutical Co., Ltd.
02
Drugs
interferon alfa
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on jRCT1080220157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080220157.